Causes of shortness of breath in patients with stable coronary heart disease

Causes of shortness of breath in patients with stable coronary heart disease

Shortness of breath is a common debilitating and limiting the quality of life symptom, which leads to frequent requests for medical help. The review summarizes data on the causes of shortness of breath in stable patients with suspected coronary heart disease (CHD), with an established diagnosis of C...

Full description

Bibliographic Details
Main Authors:	S. F. Yarmedova, I. S. Yavelov, O. M. Drapkina
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2022-10-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	стабильная ишемическая болезнь сердца одышка ишемия миокарда
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/3334

Similar Items

Importance of early diagnostics of chronic obstructive pulmonary disease in patients with coronary heart disease
by: A. N. Kuznetsov, et al.
Published: (2011-06-01)

Clinico-angiographic parallels in patients with coronary atherosclerosis risk factors
by: A. I. Koryakov
Published: (2006-06-01)

Possibilities of atorvastatin loading dose using for the prevention of perioperative myocardial damage in patients with stable coronary artery disease
by: A. S. Ragozina, et al.
Published: (2019-11-01)

Stable coronary heart disease treatment: focus on beta-adrenoblockers
by: V. I. Makolkin
Published: (2008-12-01)

The quality of received drug therapy in patients with stable coronary heart disease according to the ALIGN (TherApy in stabLe Coronary Artery dIsease Patients According to Clinical GuideliNes) study
by: E. D. Zharkova, et al.
Published: (2022-10-01)

Eurasian Guidelines for the diagnostics and management of stable coronary artery disease (2020-2021)
by: Yu. A. Karpov, et al.
Published: (2021-09-01)

Psychogenic dyspnea and hypocapnia in men with ischemic heart disease before and after CABG
by: O. V. Grishin, et al.
Published: (2018-06-01)

EVALUATION OF MYOCARDIAL REVASCULARIZATION IN STABLE CORONARY HEART DISEASE PATIENTS AND FACTORS ASSOCIATED WITH INVASIVE STRATEGY CHOICE
by: A. S. Korotin, et al.
Published: (2017-08-01)

New potential of Trimetazidine MB for coronary heart disease treatment in the real-world clinical practice: results of the Russian multi-centre randomised study PERSPECTIVE (Part II)
by: M. G. Bubnova, et al.
Published: (2011-12-01)

Multivariate analysis of medication adherence among outpatients with stable coronary artery disease
by: S. B. Fitilev, et al.
Published: (2022-02-01)

Effect of medication adherence on the risk of cardiovascular events in outpatients with stable coronary artery disease: results of two-year monitoring
by: S. B. Fitilev, et al.
Published: (2023-04-01)

Nitrates in complex angina management during the age of aggressive coronary atherosclerosis treatment
by: D. M. Aronov, et al.
Published: (2005-10-01)

Various protocols of extracorporeal shock wave therapy in the treatment of stable angina
by: M. M. Shcherbak, et al.
Published: (2019-11-01)

ENDOTHELIAL DYSFUNCTION IN STABLE ANGINA AND MYOCARDIAL INFARCTION COMBINED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: M. A. Popova, et al.
Published: (2015-12-01)

Myocardial revascularization effects on vascular endothelial growth factor and transforming growth factor β-1 in coronary heart disease patients
by: I. V. Sergienko, et al.
Published: (2007-10-01)

Effects of Pharmacy Care Program on medication adherence in outpatients with stable coronary artery disease: a randomized controlled study
by: S. B. Fitilev, et al.
Published: (2022-01-01)

CARBOHYDRATE METABOLISM DISORDERS AND CORONARY HEART DISEASE: PROGNOSTIC VALUE AND REVASCULARISATION EFFECTIVENESS
by: L. V. Kremneva, et al.
Published: (2013-06-01)

Ivabradine potential for correcting myocardial electrical instability predictors in coronary heart disease
by: I. P. Tatarchenko, et al.
Published: (2008-12-01)

High-definition electrocardiography, heart rate variability and QT interval assessment in coronary heart disease diagnostics during professional medical examination of railroad workers
by: A. E. Radzevich, et al.
Published: (2006-02-01)

Arterial hypertension and myocardial electric heterogeneity in patients with coronary heart disease
by: L. A. Leshchinsky, et al.
Published: (2005-06-01)

Secondary prevention of coronary heart disease in Moscow-population patients with myocardial infarction
by: R. G. Oganov, et al.
Published: (2005-06-01)

Predictors of long term adverse events after scheduled endovascular coronary interventions
by: E. O. Vershinina, et al.
Published: (2018-08-01)

LIFE QUALITY ASSESSMENT OF PATIENTS WITH STABLE CORONARY ARTERY DISEASE AFTER MYOCARDIAL REVASCULARIZATION
by: I. A. Narkevich, et al.
Published: (2021-05-01)

EVALUATION OF RANOLAZINE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC STABLE ANGINA. RESULTS FROM THE TERISA RANDOMIZED CLINICAL TRIAL (TYPE 2 DIABETES EVALUATION OF RANOLAZINE IN SUBJECTS WITH CHRONIC STABLE ANGINA)
Published: (2015-09-01)

Helicobacter pylori infection, esophagitis severity, and myocardial electrical instability in patients with coronary heart disease and gastroesophageal reflux disease
by: S. V. Loginov, et al.
Published: (2006-08-01)

PREDICTION OF THE INFLUENCE OF ORIGINAL AND GENERIC ROSUVASTATIN ON DIRECT MEDICAL COSTS OF SECONDARY PREVENTION IN PATIENTS WITH CHRONIC TYPES OF ISCHEMIC HEART DISEASE
by: E. I. Tarlovskaya, et al.
Published: (2015-08-01)

Prevention of cardiovascular events in patients with stable coronary artery disease: myocardial revascularization or pharmacological treatment?
by: I. S. Yavelov
Published: (2021-05-01)

HIGH SELECTIVE LONG-ACTING Β1-BLOCKER WITH A VASODILATING EFFECT NEBIVOLOL IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE
by: V. P. Lupanov
Published: (2015-12-01)

Mortality from acute types of coronary artery disease in men and women in Russia in 2015 and 2019
by: I. V. Samorodskaya, et al.
Published: (2022-07-01)

COMPLEX APPROACHES TO TREATMENT OF DYSLIPIDEMIA IN PATIENTS WITH ISHEMIC HEART DISEASE
by: M. A. Chichkova, et al.
Published: (2015-10-01)

Trimetazidine MR effects on heart remodeling in stable coronary heart disease patients
by: E. M. Khurs, et al.
Published: (2007-02-01)

Possibilities of detecting and correcting decreased heart rate variability in patients with coronary artery disease in combination with depressive disorders in a cardiology department
by: T. G. Nonka, et al.
Published: (2021-07-01)

MICROCIRCULATORY ISCHEMIA AND STATINS: LESSONS OF INTERVENTION CARDIOLOGY
by: An. A. Alexandrov, et al.
Published: (2015-12-01)

Right heart remodeling in coronary heat disease: clinico-pathophysiological correlations
by: N. S. Buslenko, et al.
Published: (2005-10-01)

Meta-analyses and systematic reviews on myocardial revascularization: comparing survival, myocardial infarction, repeated revascularization and angina symptom reduction rates
by: I. V. Samorodskaya
Published: (1970-01-01)

Multi-center randomized trial on the impact of “CONFIDENCE” communication program aimed at evaluating therapy adherence of patients with registered myocardial infarction who underwent successful revascularization by stenting or thrombolysis after discharg
by: А. Р. Таркова, et al.
Published: (2017-04-01)

DEPRESSION, ANXIETY AND MYOCARDIAL INFARCTION: EVERYTHING JUST BEGINS (PART I)
by: Y. A. Vasyuk, et al.
Published: (2015-12-01)

DEPRESSION, ANXIETY AND MYOCARDIAL INFARCTION: EVERYTHING JUST BEGINS. PART II
by: Y. A. Vasyuk, et al.
Published: (2015-12-01)

Identification of coronary artery lesions and tactics of surgical treatment in patients with chronic lower limb ischemia
by: V. S. Arakelyan, et al.
Published: (2022-06-01)

Secondary prevention drug therapy of coronary heart disease and myocardial infarction
by: V. P. Lupanov
Published: (2013-12-01)